The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I think I’m just going to hold this now long term and sit on it, can’t see budd getting any sales atm, gutted, but I’m. It going to sell, il keep my holding fingers crossed something changes fast
Bigal I fear your bad maths .. you said SP would be a minimum of £5.89 from PCR alone!!
Monday, Jan 17th 2022 9PM - Daily Mail:-
Fauci, director of the National Institute of Allergies and Infectious Disease, told the Davos Agenda virtual event Monday that 'natural vaccination' - or immunity via previous infection - might not be as effective as some believe.
Like the emergence of Omicron, there is potential for a new variant to emerge in the future that can bypass the natural immunity provided by infection from the new strain.
He says that even if Omicron - which has caused a massive surge in new cases worldwide but is not as severe or deadly as its predecessors - is the final strain of Covid, it will likely become endemic.
His warning runs counter to the positive predictions coming from some officials in the UK who believe that the virus could have a 'flu-type' relationship with people by the end of the year based on its current spread.
Fauci has previously made grim projections about new Covid variants, and was even correct about a variant like Omicron emerging.
In August, when the Delta variant was first rising in the U.S., Fauci warned that with transmission of Covid so rampant it was likely that a vaccine resistant variant would eventually emerge.
Months later, than variant did come about, when South African health officials discovered the highly infectious Omicron variant in late November.
He fears that there is a chance another variant emerges that has mutated in a way that allows it to get around protection provided by recovering from Omicron.
Cmon people,its obvious the poc is never going to achieve anything!its clear as day,to little to late.
Until it’s a Smiler moment… which I am thinking more and more likely here now…
GLA
But that wouldn’t stop Rog the Dodge posting and spreading untruths.A few others joining in to try and put the boot in as it gives them a little thrill in their mundane lives.Will be upping my holding substantially in the near future.Love a rollercoaster lol
I would have assumed they would have sold out around 70 or even earlier
I.e. PoC/LAMP application is where you want a molecular test on the spot. The likes of the one below are not that.
I'll tell you waht, those iis which came on board with £6m at 25p must be absolutely thrilled with the way things are going just now... IMO if Budd sold them lies the way he has the general market then they'll be after more than just his resignation...OOh could get nasty. Maybe that's why he's gone to ground and isn't saying anything.
Had a look at that 'breathalyser'. It's neither an antigen nor a molecular test. It may be useful where neither is required or specified, however it is not in the same category as gdr's LAMP. That is all.
agreed speculate2 but ...isn't it a death knell? A nail in the coffin for sure. Will be intrigued to see if Budd says anything about this. I suspect not as I'm personally convinced he already knows there are no sales of the POC product forthcoming. Lths know him well enough that if there had been even half a sniff he'd have announced or hinted at it well before anything was signed and sealed in terms of contracts.
We don't need to worry about this, Bruno says sales RNS this week and he's never wrong!
if true - about Fnnish development - compleete death nail for GDRs POC albeit a breath test must have limitations on identification compared to the high level of LAMP tests
Just posted by Luckenbach on the SNG board
from a press release in 14th of Jan)
“Finnish medical device company Deep Sensing Algorithms Ltd (DSA) has completed the development of the world’s first ultra-rapid COVID-19 detection technology. The DSA BreathPass™ solution, which provides a result in less than a minute, now carries the EU wide medical CE certification and is available for deliveries.
DSA BreathPass™ is a portable, handheld device that analyses exhaled breath to detect COVID-19 infection. The human defense mechanisms start immediately after the infection and the metabolic byproducts of the person’s immune response start to appear in exhaled breath within the same day.
The product is simple to use – an individual simply breathes once into the device, and an algorithm provides a result after the measuring period of 45 seconds. The device can be ready for the next individual in 2 minutes.
The solution is intended for detecting COVID-19 infection in both asymptomatic and pre-symptomatic people. Due to the early warning nature of the COVID-19 detection, it is suited for screening applications where healthy feeling and asymptomatic people wish to receive assurance of their condition. “